![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 20, 18061-18068, May 17, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§¶,
,
,
,
,

, and
§§
From the The DNA mismatch repair (MMR)
proteins are essential for the maintenance of genomic stability of
human cells. Compared with hereditary or even sporadic carcinomas, MMR
gene mutations are very uncommon in leukemia. However, genetic
instability, attested by either loss of heterozygosity or
microsatellite instability, has been extensively documented in chronic
or acute malignant myeloid disorders. This observation suggests that in
leukemia some internal or external signals may interfere with MMR
protein expression and/or function. We investigated the effects of
protein kinase C (PKC) stimulation by
12-O-tetradecanoylphorbol-13-acetate (TPA) on MMR protein
expression and activity in human myeloid leukemia cell lines. First, we
show here that unstimulated U937 cells displayed low level of PKC
activity as well as MMR protein expression and activity compared with a
panel of myeloid cell lines. Second, treatment of U937 cells with TPA
significantly increased (3-5-fold) hMSH2 expression and, to a lesser
extent, hMSH6 and hPMS2 expression, correlated to a restoration of MMR function. In addition, diacylglycerol, a physiological PKC agonist, induced a significant increase in hMSH2 expression, whereas
chelerythrine or calphostin C, two PKC inhibitors, significantly
decreased TPA-induced hMSH2 expression. Reciprocally, treatment of HEL
and KG1a cells that exhibited a high level of PKC expression, with
chelerythrine significantly decreased hMSH2 and hMSH6 expression.
Moreover, the alteration of MMR protein expression paralleled the
difference in microsatellite instability and cell sensitivity to
6-thioguanine. Our results suggest that PKC could play a role in
regulating MMR protein expression and function in some myeloid
leukemia cells.
Institut de Pharmacologie et de Biologie
Structurale, UMR 5089, CNRS, 205 route de Narbonne, 31077 Toulouse
cedex, France,
E9910, INSERM, Institut Claudius Régaud,
20-24 rue du Pont St Pierre, 31052 Toulouse cedex, France, and
** Laboratoire d'Anatomie Pathologique, Hôpital
Purpan, Place du Dr. Baylac, 31059 Toulouse cedex, France

To whom correspondence may be addressed: Institut de
Pharmacologie et de Biologie Structurale, UMR CNRS 5089, 205 route de Narbonne, 31077 Toulouse cedex, France. Tel.: 33-5-61-17-59-36; Fax:
33-5-61-17-59-33; E-mail: bernard.salles@ipbs.fr.
§§
To whom correspondence may be addressed: INSERM E9910, Institut
Claudius Régaud, 20 rue du Pont St Pierre, 31052 Toulouse cedex,
France. E-mail: lautier@icr.fnclcc.fr.
This article has been cited by other articles:
![]() |
M. R. Velangi, E. C. Matheson, G. J. Morgan, G. H. Jackson, P. R. Taylor, A. G. Hall, and J. A.E. Irving DNA mismatch repair pathway defects in the pathogenesis and evolution of myeloma Carcinogenesis, October 1, 2004; 25(10): 1795 - 1803. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Humbert, I. Achour, D. Lautier, G. Laurent, and B. Salles hMSH2 expression is driven by AP1-dependent regulation through phorbol-ester exposure Nucleic Acids Res., October 1, 2003; 31(19): 5627 - 5634. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |